0.7066

13.56% 0.0844

Cytosorbents Corp (CTSO)

Overview News Price History Option Chain Financials Why CTSO Down? Discussions Forecast Stock Split

Cytosorbents Corp stock is traded at $0.7066, with a volume of 172.36K. It is up +13.56% in the last 24 hours and down -14.68% over the past month. CytoSorbents Corp specializes in treating life-threatening conditions in intensive care and cardiac surgery using proprietary polymer adsorption technology. Its flagship product, CytoSorb, is approved in the EU as an extracorporeal cytokine absorber, aiming to reduce inflammation and prevent multiple organ failure in critical illnesses like sepsis and trauma. Revenue primarily comes from product sales in Germany, with additional income from grant agencies in the United States. The company operates through Direct sales and Distributors/strategic partners in United States, Germany and Other Countries. The company's product consists of Cytosorb, ECOS-300CY, VetResQ, HemoDefend, and DrugSorb-ATR.

Previous Close:

$0.6222

Open:

$0.6222

24h Volume:

172.36K

Relative Volume:

1.76

Market Cap:

$44.38M

Revenue:

$33.79M

Net Income/Loss:

$-18.67M

P/E Ratio:

-1.9726

EPS:

-0.3582

Net Cash Flow:

$-19.17M

1W Performance:

+7.06%

1M Performance:

-14.68%

6M Performance:

-18.78%

1Y Performance:

-20.61%

1-Day Range:

$0.6101

$0.7124

1-Week Range:

$0.60

$0.7124

52-Week Range:

$0.60

$1.61

Cytosorbents Corp Stock (CTSO) Company Profile

Name

Cytosorbents Corp

Sector

Healthcare (1129)

Industry

Medical Devices (143)

Phone

973-329-8885

Address

305 COLLEGE ROAD EAST, PRINCETON, NJ

Employee

149

Twitter

@CytoSorbents

Next Earnings Date

2025-03-31

Latest SEC Filings

CTSO's Discussions on Twitter

Compare CTSO with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
CTSO Cytosorbents Corp	0.7066	39.08M	33.79M	-18.67M	-19.17M	-0.3582
ABT Abbott Laboratories	128.11	215.57B	43.84B	13.90B	6.92B	7.9725
BSX Boston Scientific Corp	96.88	143.20B	19.35B	2.78B	3.82B	1.8696
SYK Stryker Corp	368.27	137.86B	24.38B	2.94B	4.07B	7.6159
MDT Medtronic Plc	101.20	127.43B	34.76B	4.79B	5.21B	3.7049
EW Edwards Lifesciences Corp	85.13	48.80B	5.88B	1.34B	799.60M	2.3489

Cytosorbents Corp Stock (CTSO) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Sep-07-23	Initiated	B. Riley Securities	Buy
Oct-14-21	Resumed	B. Riley Securities	Buy
Sep-17-20	Initiated	Jefferies	Buy
Sep-01-20	Initiated	SVB Leerink	Outperform
Aug-08-17	Reiterated	Maxim Group	Buy
Oct-26-16	Initiated	Aegis Capital	Buy
May-24-16	Initiated	Maxim Group	Buy
Oct-29-15	Upgrade	WBB Securities	Speculative Buy → Buy
May-12-15	Reiterated	MLV & Co	Buy
Apr-01-15	Reiterated	MLV & Co	Buy
Mar-05-15	Initiated	MLV & Co	Buy
Feb-25-15	Initiated	WBB Securities	Speculative Buy
Jan-27-15	Reiterated	H.C. Wainwright	Buy

View All

Cytosorbents Corp Stock (CTSO) Latest News

Nov 20, 2025

How Cytosorbents Corporation (HQE1) stock responds to bond marketJuly 2025 Outlook & Real-Time Stock Price Movement Reports - newser.com

Nov 20, 2025

Zacks Small Cap Weighs in on Cytosorbents Q1 Earnings - Defense World

Nov 20, 2025

Nov 19, 2025

Will Cytosorbents Corporation (HQE1) stock remain on Wall Street radarBull Run & Reliable Volume Spike Trade Alerts - newser.com

Nov 19, 2025

How buyback programs support Cytosorbents Corporation (HQE1) stockStock Surge & AI Driven Price Predictions - newser.com

Nov 19, 2025

Nov 18, 2025

CytoSorbents at Jefferies London: Strategic Growth and Regulatory Pathways - Investing.com

Nov 18, 2025

Is Cytosorbents Corporation (HQE1) stock a top pick for value investorsBuy Signal & Consistent Return Investment Signals - newser.com

Nov 18, 2025

Combining price and volume data for Cytosorbents CorporationJuly 2025 Trade Ideas & Fast Moving Stock Trade Plans - newser.com

Nov 18, 2025

Will Cytosorbents Corporation (HQE1) stock benefit from Fed rate cutsForecast Cut & Weekly Consistent Profit Watchlists - newser.com

Nov 18, 2025

Nov 17, 2025

Updated: CytoSorbents to Present at the Jefferies Global Healthcare Conference in London - PR Newswire

Nov 17, 2025

Cytosorbents’ (CTSO) Buy Rating Reiterated at D. Boral Capital - Defense World

Nov 17, 2025

HC Wainwright Cuts Cytosorbents (NASDAQ:CTSO) Price Target to $0.75 - Defense World

Nov 17, 2025

Nov 16, 2025

Published on: 2025-11-16 10:30:06 - newser.com

Nov 16, 2025

Using Python tools to backtest Cytosorbents Corporation strategiesMarket Performance Report & Weekly Breakout Opportunity Watchlist - newser.com

Nov 16, 2025

Nov 15, 2025

CytoSorbents price target lowered to 75c from $1 at H.C. Wainwright - MSN

Nov 15, 2025

Will Cytosorbents Corporation stock recover faster than marketMarket Volume Report & Free Community Consensus Stock Picks - newser.com

Nov 15, 2025

Will breakout in Cytosorbents Corporation lead to full recoveryGap Up & Free Fast Entry Momentum Trade Alerts - newser.com

Nov 15, 2025

CytoSorbents implemented workforce and cost reduction program - MSN

Nov 15, 2025

Published on: 2025-11-15 12:38:52 - newser.com

Nov 15, 2025

Can machine learning forecast Cytosorbents Corporation recoveryTrade Ideas & Weekly Breakout Opportunity Watchlist - newser.com

Nov 15, 2025

Cytosorbents Corporation (HQE1.F) Stock Price, News, Quote & History - Yahoo! Finance Canada

Nov 15, 2025

Nov 14, 2025

Cytosorbents Corp’s Earnings Call: Growth Amid Challenges - TipRanks

Nov 14, 2025

CTSO: Analyst Maintains Buy Rating with Steady Price Target of $10.00 | CTSO Stock News - GuruFocus

Nov 14, 2025

CTSO Analyst Rating Update: HC Wainwright Lowers Price Target | - GuruFocus

Nov 14, 2025

Cytosorbents Corporation (NASDAQ:CTSO) Q3 2025 Earnings Call Transcript - Insider Monkey

Nov 14, 2025

CytoSorbents: Q3 Earnings Snapshot - Connecticut Post

Nov 14, 2025